Sofinnova Investments’s uniQure QURE Stock Holding History

Sofinnova Investments’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500,000	Closed	-$29.2M	–	69
2025 Q3	$29.2M	Buy	+500,000	New	+$9.08M	1.6%	22

Other funds holding QURE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Sofinnova Investments's QURE Position: Q1 2026 in Review

Sofinnova Investments sold out of uniQure (QURE) in Q1 2026, closing a stake of 176,513 shares — an estimated $4.22M sold.

Sofinnova Investments first reported a position in QURE in Q1 2021 and held it in 8 quarters. The position peaked at $21.7M in Q2 2025. 212 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Sofinnova Investments reported no remaining uniQure position as of Q1 2026 after selling out during the quarter.
Sofinnova Investments sold 176,513 uniQure shares in Q1 2026, an estimated $4.22M.
Sofinnova Investments first reported a position in uniQure in Q1 2021 and held it in 8 quarters.
Sofinnova Investments's uniQure position peaked at $21.7M in Q2 2025.
212 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.